First Trust Advisors LP Revance Therapeutics, Inc. Transaction History

First Trust Advisors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$11.47 - $25.07 $299,034 - $653,599	-26,071 Reduced 23.94%	82,845 $950,000
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $2.69 Million - $4.1 Million	108,916 New	108,916 $2.76 Million
Q2 2022 Aug 12, 2022	SELL	$11.52 - $20.4 $284,002 - $502,921	-24,653 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$12.36 - $20.31 $408,893 - $671,895	-33,082 Reduced 57.3%	24,653 $481,000
Q4 2021 Feb 08, 2022	BUY	$12.46 - $27.87 $27,299 - $61,063	2,191 Added 3.94%	57,735 $942,000
Q3 2021 Nov 15, 2021	BUY	$25.78 - $33.21 $907,713 - $1.17 Million	35,210 Added 173.16%	55,544 $1.55 Million
Q2 2021 Aug 16, 2021	SELL	$26.8 - $31.84 $1.41 Million - $1.68 Million	-52,682 Reduced 72.15%	20,334 $603,000
Q1 2021 May 14, 2021	BUY	$24.03 - $29.97 $953,558 - $1.19 Million	39,682 Added 119.04%	73,016 $2.04 Million
Q4 2020 Feb 02, 2021	SELL	$23.41 - $28.34 $525,577 - $636,261	-22,451 Reduced 40.25%	33,334 $945,000
Q3 2020 Nov 05, 2020	SELL	$23.23 - $34.3 $75,102 - $110,891	-3,233 Reduced 5.48%	55,785 $1.4 Million
Q2 2020 Jul 22, 2020	BUY	$12.6 - $26.55 $743,626 - $1.57 Million	59,018 New	59,018 $1.44 Million
Q2 2019 Jul 30, 2019	SELL	$10.67 - $15.49 $196,018 - $284,566	-18,371 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$15.4 - $20.39 $282,913 - $374,584	18,371 New	18,371 $290,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.